Crispr insertion of gene circuits for on-demand timp production in post-traumatic osteoarthritis
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110162
- Recipient
-
Vanderbilt University UEI GTNBNWXJ12D5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $316,753
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Nashville, TN 37203, USA
Award details come from USAspending.gov.
About this award
Vanderbilt University was awarded a $316,753 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to develop CRISPR gene insertion techniques for on-demand production of Tissue Inhibitor of Metalloproteinases (TIMP) in cases of post-traumatic osteoarthritis. The goal is to transform treatment for service members and the public through innovative biomedical research solutions applicable to battlefield medicine and other contexts. The work will be performed at Vanderbilt University's facilities in Nashville, Tennessee.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $316,753 |
Quick answers
Who received award W81XWH2110162?
W81XWH2110162 was awarded to Vanderbilt University by Defense Health Agency (Department of Defense) on March 1, 2021.
How much is award W81XWH2110162 worth?
$316,753 has been obligated on W81XWH2110162.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award